Pertussis vaccine--an analysis of benefits, risks and costs.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 39253)

Published in N Engl J Med on October 25, 1979

Authors

J P Koplan, S C Schoenbaum, M C Weinstein, D W Fraser

Articles citing this

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02

Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull World Health Organ (1984) 1.99

The contributions of biomedical informatics to the fight against bioterrorism. J Am Med Inform Assoc (2002) 1.75

ABC of 1 to 7: whooping cough. Br Med J (Clin Res Ed) (1982) 1.14

Risk language preferred by mothers in considering a hypothetical new vaccine for their children. CMAJ (1992) 1.11

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. PLoS One (2010) 0.98

Immunizing California's children. Effects of current policies on immunization levels. West J Med (1990) 0.86

Evaluating the benefits of increasing measles immunization rates. Health Serv Res (2001) 0.77

Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene. Plant Cell Rep (2007) 0.77

Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany. Eur J Pediatr (1998) 0.76

Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. PLoS One (2015) 0.76

Vaccination and the onset of dravet syndrome. Epilepsy Curr (2011) 0.75

Pertussis: should we immunise neurologically disabled and developmentally delayed children? Br Med J (Clin Res Ed) (1983) 0.75

Immunisation practice and policy. J Epidemiol Community Health (1984) 0.75

Articles by these authors

Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00

Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med (1977) 24.44

The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84

The spread of the obesity epidemic in the United States, 1991-1998. JAMA (1999) 11.52

Performance of a five-item mental health screening test. Med Care (1991) 8.76

Health literacy among Medicare enrollees in a managed care organization. JAMA (1999) 8.63

Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med (1977) 8.60

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 8.52

Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85

Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal (1995) 7.45

Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med (1998) 7.26

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA (1996) 6.80

Health reform and the health of the public. Forging community health partnerships. JAMA (1994) 6.18

The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89

The relationship between method of physician payment and patient trust. JAMA (1998) 5.56

The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA (1997) 5.36

The cost of a successful delivery with in vitro fertilization. N Engl J Med (1994) 4.94

Atypical Legionella-like organisms: fastidious water-associated bacteria pathogenic for man. Lancet (1979) 4.62

Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry (1987) 4.62

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making (1985) 4.47

Gains in life expectancy from medical interventions--standardizing data on outcomes. N Engl J Med (1998) 4.47

Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis (1975) 4.02

A 2020 vision for American health care. Arch Intern Med (2000) 4.01

Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation (1991) 3.75

Patients' trust in their physicians: effects of choice, continuity, and payment method. J Gen Intern Med (1998) 3.51

Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health (1985) 3.31

Legionnaires' disease outbreak at an Atlanta, Georgia, Country Club: evidence for spread from an evaporative condenser. Am J Epidemiol (1980) 3.30

Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27

Epidemiology as a liberal art. N Engl J Med (1987) 3.13

An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med (1986) 3.12

Internists' practices in health promotion and disease prevention. A survey. Ann Intern Med (1991) 3.00

Aspergillosis and other systemic mycoses. The growing problem. JAMA (1979) 2.96

Caloric imbalance and public health policy. JAMA (1999) 2.92

The swine-influenza decision. N Engl J Med (1976) 2.91

Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89

Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA (1985) 2.87

Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA (2001) 2.86

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85

Use and misuse of the term "cost effective" in medicine. N Engl J Med (1986) 2.82

Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80

The continuing epidemic of obesity in the United States. JAMA (2000) 2.80

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med (2000) 2.71

The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69

Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health (1985) 2.58

Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension. N Engl J Med (1977) 2.54

When doctors meet numbers. Am J Med (1981) 2.48

A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health (1988) 2.46

Optimal methods for guideline implementation: conclusions from Leeds Castle meeting. Med Care (2001) 2.41

Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care (2000) 2.41

Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol (2001) 2.37

The diagnosis of Legionnaires' disease. Ann Intern Med (1978) 2.36

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA (1999) 2.35

Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med (1979) 2.34

Spread of meningococcal infection within households. Lancet (1974) 2.32

The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29

Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28

Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease. Lancet (1978) 2.28

Review of the epidemiologic evidence for an association between infant feeding and infant health. Pediatrics (1984) 2.27

Who gets chemotherapy for metastatic lung cancer? Chest (2000) 2.27

Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med (1991) 2.25

The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA (1986) 2.22

Tubal infertility and the intrauterine device. N Engl J Med (1985) 2.22

Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med (2000) 2.21

Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis (1982) 2.20

Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA (1986) 2.18

Association of maternal hematocrit with premature labor. Am J Obstet Gynecol (1988) 2.18

Preference-based measures in economic evaluation in health care. Annu Rev Public Health (2000) 2.18

A major focus of Legionnaires' disease in Bloomington, Indiana. Ann Intern Med (1979) 2.16

Legionnaires' disease: clinical features of the epidemic in Philadelphia. Ann Intern Med (1979) 2.10

On the decision rules of cost-effectiveness analysis. J Health Econ (1993) 2.09

The cost-effectiveness of air bags by seating position. JAMA (1997) 2.09

Epidemiologic aspects of legionellosis. Epidemiol Rev (1979) 2.03

Influenza vaccine--unacceptable or unaccepted. Am J Public Health (1979) 2.02

Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA (1990) 2.01

Prevalence of ampicillin- and chloramphenicol-resistant strains of Haemophilus influenzae causing meningitis and bacteremia: national survey of hospital laboratories. J Infect Dis (1978) 2.01

No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med (1982) 2.01

Detection by radioimmunoassay of antibodies in human smallpox patients and vaccinees. J Clin Microbiol (1975) 2.01

Cost and health implications of cholesterol lowering. Circulation (1992) 2.00

Preferences for health outcomes. Comparison of assessment methods. Med Decis Making (1984) 1.97

What do patients value? Willingness to pay for ultrasound in normal pregnancy. Med Care (1985) 1.96

Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92

Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92

Risk factors accounting for racial differences in the rate of premature birth. N Engl J Med (1987) 1.91

Elective hysterectomy. Benefits, risks, and costs. Med Care (1985) 1.87

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology (1999) 1.87

Failure of Legionella pneumophila sensitivities to predict culture results from disinfectant-treated air-conditioning cooling towers. Appl Environ Microbiol (1982) 1.85

An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacterium. J Infect Dis (1978) 1.84

A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am J Prev Med (1991) 1.84

Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med (1987) 1.80

Benefit-cost analysis of rubella vaccination policy. N Engl J Med (1976) 1.79

Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. J Infect Dis (1981) 1.76

An epidemiologic study of the benefits and risks of running. JAMA (1982) 1.76

Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol (1986) 1.75

Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. JAMA (1980) 1.74

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol (2001) 1.72

Cigarette smoking in China. Prevalence, characteristics, and attitudes in Minhang District. JAMA (1995) 1.72